When Panel Testing Misses the Mark: Navigating Whole Exome Sequencing for Cardiovascular Genomic Disorders with Megan Betts, MS, LGC

• Join us to discuss what happens when cardiovascular panel testing falls short in the diagnosis of our phenotypically positive patients and their relatives. Learn how the utilization of familial WES can fill the gap in knowledge and shorten diagnostic odyssey for patients with hereditary cardiovascular disease.

  Level of Instruction: Basic

  

  Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.

  

  Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.

Megan Betts, MS, LGC | Presenter

Program Director of Precision Medicine

Megan Betts, MS, LGC is a board-certified, licensed, genetic counselor currently employed by WellSpan Health as Program Director of Precision Medicine. With 7 years’ clinical experience in cardiovascular genetics and genomics, Megan has led the design and implementation of multiple cardiovascular genetics clinical pathways, as well as staffed broad population genomic screening programs. Her current interest in the utilization of population genomics first screening to identify those with inherited disease before phenotype may express in the family, has led to additional awareness in how early identification via WES may change the course of a family’s diagnostic odyssey in the clinical cardiovascular space. The ability to utilize WES and WGS data to diagnose patients—instead of multiple lab draws and panel screenings over a patients lifetime—is what excites Megan most about the changing landscape of cardiovascular genomics.